153 related articles for article (PubMed ID: 22244823)
41. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts.
Inoue H; Takamori M; Shimoyama Y; Ishibashi H; Yamamoto S; Koshihara Y
Br J Pharmacol; 2002 May; 136(2):287-95. PubMed ID: 12010778
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
Davis TL; Sharif NA
Br J Pharmacol; 2000 Aug; 130(8):1919-26. PubMed ID: 10952683
[TBL] [Abstract][Full Text] [Related]
43. Central PGE2 exhibits anxiolytic-like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5-HT1A, dopamine D1 and GABAA receptors.
Suzuki C; Miyamoto C; Furuyashiki T; Narumiya S; Ohinata K
FEBS Lett; 2011 Jul; 585(14):2357-62. PubMed ID: 21693121
[TBL] [Abstract][Full Text] [Related]
44. Prostanoid receptors involved in the relaxation of human pulmonary vessels.
Walch L; Labat C; Gascard JP; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 1999 Feb; 126(4):859-66. PubMed ID: 10193765
[TBL] [Abstract][Full Text] [Related]
45. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP₂ receptor antagonist.
af Forselles KJ; Root J; Clarke T; Davey D; Aughton K; Dack K; Pullen N
Br J Pharmacol; 2011 Dec; 164(7):1847-56. PubMed ID: 21595651
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.
Shoji Y; Takahashi M; Kitamura T; Watanabe K; Kawamori T; Maruyama T; Sugimoto Y; Negishi M; Narumiya S; Sugimura T; Wakabayashi K
Gut; 2004 Aug; 53(8):1151-8. PubMed ID: 15247185
[TBL] [Abstract][Full Text] [Related]
47. Role of PGE(2) in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea.
Lan RS; Knight DA; Stewart GA; Henry PJ
Br J Pharmacol; 2001 Jan; 132(1):93-100. PubMed ID: 11156565
[TBL] [Abstract][Full Text] [Related]
48. 8-iso-PGE2 stimulates anion efflux from airway epithelial cells via the EP4 prostanoid receptor.
Joy AP; Cowley EA
Am J Respir Cell Mol Biol; 2008 Feb; 38(2):143-52. PubMed ID: 17690331
[TBL] [Abstract][Full Text] [Related]
49. Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants.
Skogvall S; Berglund M; Dalence-Guzmán MF; Svensson K; Jönsson P; Persson CG; Sterner O
Pulm Pharmacol Ther; 2007; 20(3):273-80. PubMed ID: 16731017
[TBL] [Abstract][Full Text] [Related]
50. PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4).
Poloso NJ; Urquhart P; Nicolaou A; Wang J; Woodward DF
Mol Immunol; 2013 Jul; 54(3-4):284-95. PubMed ID: 23337716
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide.
Ross RA; Craib SJ; Stevenson LA; Pertwee RG; Henderson A; Toole J; Ellington HC
J Pharmacol Exp Ther; 2002 Jun; 301(3):900-7. PubMed ID: 12023517
[TBL] [Abstract][Full Text] [Related]
52. Thromboxane prostanoid receptor activation amplifies airway stretch-activated contractions assessed in perfused intact bovine bronchial segments.
Hernandez JM; Janssen LJ
J Pharmacol Exp Ther; 2011 Oct; 339(1):248-56. PubMed ID: 21768224
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
54. BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache.
Maubach KA; Davis RJ; Clark DE; Fenton G; Lockey PM; Clark KL; Oxford AW; Hagan RM; Routledge C; Coleman RA
Br J Pharmacol; 2009 Jan; 156(2):316-27. PubMed ID: 19154437
[TBL] [Abstract][Full Text] [Related]
55. Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth Muscle.
Nayak AP; Javed E; Villalba DR; Wang Y; Morelli HP; Shah SD; Kim N; Ostrom RS; Panettieri RA; An SS; Tang DD; Penn RB
Am J Respir Cell Mol Biol; 2023 Nov; 69(5):584-591. PubMed ID: 37523713
[TBL] [Abstract][Full Text] [Related]
56. Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells.
Friis UG; Stubbe J; Uhrenholt TR; Svenningsen P; Nüsing RM; Skøtt O; Jensen BL
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F989-97. PubMed ID: 15985651
[TBL] [Abstract][Full Text] [Related]
57. Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi.
Matera MG; Calzetta L; Parascandolo V; Curradi G; Rogliani P; Cazzola M
Pulm Pharmacol Ther; 2009 Dec; 22(6):478-82. PubMed ID: 19393327
[TBL] [Abstract][Full Text] [Related]
58. EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts.
Largo R; Díez-Ortego I; Sanchez-Pernaute O; López-Armada MJ; Alvarez-Soria MA; Egido J; Herrero-Beaumont G
Ann Rheum Dis; 2004 Oct; 63(10):1197-204. PubMed ID: 15361371
[TBL] [Abstract][Full Text] [Related]
59. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
60. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors.
Petrucci G; De Cristofaro R; Rutella S; Ranelletti FO; Pocaterra D; Lancellotti S; Habib A; Patrono C; Rocca B
J Pharmacol Exp Ther; 2011 Feb; 336(2):391-402. PubMed ID: 21059804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
